About
Anne Chun Longo is the co-founder of PharmatrophiX and served as its founding CEO from 2006 to 2025; she is now a Senior Advisor to the neurodegeneration biotech company. Her background spans academic medicine and development, including strategic philanthropic fundraising for neuroscience and cancer programs at Stanford University. Publicly available evidence positions her as an operator and connector in biotech and translational medicine rather than a fund manager or documented personal investor.
Areas of interest
biotechneurodegenerative diseasealzheimers diseasehuntingtons diseasetranslational neuroscienceacademic medicinephilanthropic fundraisingpatient advocacy